AI-Powered Personalized Oncology Nutrition Market 2034

Report Description

This report is updated with the latest market data and insights as of June 2026. Base year: 2025  |  Forecast period: 2026-2034

AI-Powered Personalized Oncology Nutrition Market Outlook

According to our latest research, the global AI-powered personalized oncology nutrition market size reached USD 718.5 million in 2025, reflecting the rapid adoption of advanced digital health solutions in oncology care. The market is experiencing robust growth with a CAGR of 17.0% from 2026 to 2034, driven by technological advancements in artificial intelligence and a growing focus on precision medicine. By 2034, the market is forecasted to reach USD 2.94 billion, fueled by increasing cancer prevalence, rising demand for personalized nutrition plans, and expanding healthcare digitalization worldwide. These findings are based on the most recent industry data and comprehensive market analysis conducted with a 2025 base year.

Get Free Sample Report

The primary growth factor for the AI-powered personalized oncology nutrition market is the escalating global cancer burden, which has necessitated innovative solutions for patient care. With cancer incidence rates continuing to rise across all major regions, healthcare providers are seeking ways to optimize patient outcomes through tailored nutritional interventions. AI-powered platforms enable the creation of highly individualized nutrition plans by analyzing patient-specific data such as genetic profiles, treatment regimens, and metabolic responses. This capability not only improves patient quality of life but also enhances treatment efficacy, as nutrition plays a critical role in patient resilience and recovery. The integration of AI in this domain is also reducing the workload on clinical nutritionists, allowing for more efficient and data-driven decision-making across diverse oncology care settings. The broader ecosystem of digital therapeutics for oncology support is reinforcing this trend by providing complementary tools that work alongside personalized nutrition platforms.

Another significant driver is the technological evolution and increasing accessibility of AI algorithms and digital health platforms. The proliferation of electronic health records (EHRs), wearable devices, and mobile health applications has generated vast amounts of patient data, which AI can leverage to deliver actionable insights. AI-powered personalized oncology nutrition solutions are now capable of real-time patient monitoring, predictive analytics, and dynamic adjustment of dietary recommendations based on ongoing treatment responses. These technological advancements are making personalized nutrition not only more effective but also scalable and accessible across diverse healthcare settings, from large hospitals to homecare environments. The growing integration with oncology precision medicine software is further expanding the analytical depth and clinical utility of these platforms.

Furthermore, supportive government policies and growing investments in healthcare IT infrastructure are accelerating market growth through 2034. Many countries are prioritizing personalized medicine and digital health innovation in their national healthcare strategies, with funding allocations increasing year over year. Public and private investment for AI-driven healthcare solutions is facilitating research and development of new platforms tailored to oncology nutrition. Collaborations between technology companies, research institutes, and healthcare providers are fostering an ecosystem that supports continuous innovation. This environment is encouraging the adoption of AI-powered personalized oncology nutrition as a standard component of comprehensive cancer care globally.

From a regional perspective, North America leads the global AI-powered personalized oncology nutrition market, accounting for the largest share in 2025. This dominance is attributed to the region's advanced healthcare infrastructure, high adoption rate of digital health technologies, and strong presence of leading market players. Europe follows closely, driven by robust research activity and favorable regulatory frameworks. The Asia Pacific region is emerging as a high-growth market, propelled by increasing healthcare investments, an expanding cancer patient pool, and rising awareness of personalized nutrition solutions. Latin America and the Middle East and Africa are also witnessing steady growth, as healthcare systems in these regions continue to modernize and integrate AI-driven solutions.

Offering Analysis

The offering segment of the AI-powered personalized oncology nutrition market is bifurcated into software and services. Software solutions form the backbone of this industry, encompassing AI-driven platforms, mobile applications, and integrated modules that facilitate personalized diet planning, nutritional assessment, and patient monitoring. These software tools leverage machine learning algorithms to analyze complex datasets, including patient medical histories, genomic data, and real-time health metrics. Software accounted for approximately 62.5% of total market revenue in 2025, underscoring its central role in driving market value. The demand for robust, user-friendly, and interoperable software is surging as healthcare providers seek scalable solutions that can seamlessly integrate with existing hospital information systems and electronic health records. The continuous evolution of AI capabilities is enabling software vendors to offer increasingly sophisticated tools that support clinical decision-making and patient engagement throughout the cancer care continuum.

Get Free Sample Report

On the other hand, the services segment, representing approximately 37.5% of market revenue in 2025, is gaining momentum as healthcare organizations require expert support for implementation, customization, training, and ongoing maintenance of AI-powered nutrition solutions. Service providers play a crucial role in bridging the gap between technology and clinical practice, ensuring that software platforms are tailored to the unique needs of oncology departments and individual patients. Consulting services, technical support, and data analytics services are in high demand, particularly in regions where digital health adoption is still in its nascent stages. The services segment is also benefiting from the trend towards value-based healthcare, where providers are incentivized to improve patient outcomes through holistic, data-driven care models that incorporate personalized nutrition as a key pillar.

The interplay between software and services is creating a dynamic market landscape, with many companies offering bundled solutions that combine cutting-edge technology with expert support. This approach is particularly attractive to hospitals and cancer care centers that require end-to-end solutions for personalized nutrition management. As the market matures through the 2026-2034 forecast period, there is a growing emphasis on interoperability, data security, and compliance with healthcare regulations, prompting vendors to invest in continuous software updates and enhanced service offerings. The emergence of platforms that combine AI-powered chronic disease coaching capabilities with oncology-specific nutrition tools is creating new bundled value propositions that appeal to integrated health systems.

Moreover, the rise of cloud-based delivery models is reshaping the offering landscape in 2025 and beyond. Cloud-based software solutions enable real-time data sharing and collaboration among multidisciplinary care teams, while service providers facilitate smooth transitions to cloud environments through migration, integration, and cybersecurity services. This synergy between software innovation and high-quality services is expected to remain a key growth driver for the AI-powered personalized oncology nutrition market throughout the forecast period, with the software segment projected to maintain its dominant position while services grow steadily as implementation complexity increases.

Application Analysis

The application segment of the AI-powered personalized oncology nutrition market is segmented into diet planning, nutritional assessment, patient monitoring, treatment support, and others. Diet planning is a cornerstone application, as AI algorithms can generate individualized meal plans that align with each patient's diagnosis, treatment protocol, and metabolic needs. By synthesizing data from medical records, genomics, and lifestyle factors, AI-powered diet planning tools help clinicians prescribe nutrition interventions that optimize patient outcomes. This application is particularly valuable in managing side effects of cancer treatments, such as chemotherapy-induced nausea or weight loss, and in supporting patients' overall well-being throughout their care journey.

Nutritional assessment is another critical application, where AI tools are used to evaluate patients' nutritional status through analysis of laboratory results, dietary intake records, and body composition metrics. These assessments enable early identification of malnutrition risks and facilitate timely interventions that can meaningfully improve treatment tolerability. Patient monitoring applications are gaining traction as wearable devices and remote health monitoring technologies become more prevalent in oncology care. AI-powered platforms can continuously track patient biomarkers, dietary adherence, and treatment responses, alerting clinicians to potential issues and enabling proactive care adjustments. This real-time monitoring capability is particularly beneficial for patients undergoing intensive cancer treatments who require close nutritional oversight. The growing integration of these platforms with AI-powered virtual oncology nurse navigator tools is enhancing care coordination and ensuring that nutrition insights are seamlessly communicated across the care team.

Treatment support applications leverage AI to provide evidence-based recommendations that complement oncology therapies. These platforms can analyze vast amounts of clinical research, patient data, and treatment guidelines to suggest nutrition strategies that enhance treatment efficacy and minimize adverse effects. For example, AI-powered systems can recommend specific nutrient supplements or dietary modifications based on a patient's genetic predispositions and treatment regimen. This level of personalization is transforming oncology nutrition from a one-size-fits-all approach to a highly individualized discipline that integrates seamlessly with broader precision medicine AI frameworks.

Tele-nutrition is emerging as a transformative approach in the field of personalized oncology nutrition, offering remote dietary consultations and support to patients. Through tele-nutrition platforms, patients can access expert nutritional advice from the comfort of their homes, making it easier to adhere to personalized nutrition plans. This approach is particularly beneficial for patients who may have difficulty traveling to healthcare facilities due to their treatment schedules or health conditions. By integrating tele-nutrition into oncology care, healthcare providers can offer continuous support and monitoring, ensuring that patients receive timely dietary adjustments and interventions. This not only enhances patient engagement but also improves the overall effectiveness of personalized nutrition strategies in cancer care.

Beyond these core applications, the "others" category includes emerging use cases such as patient education, risk stratification, and predictive analytics for long-term survivorship planning. AI-powered educational tools can empower patients with tailored information about nutrition and self-care, while predictive models can help clinicians anticipate future nutritional challenges and design preventive strategies. The expanding range of applications underscores the versatility and transformative potential of AI in personalized oncology nutrition as the market progresses through the 2026-2034 forecast period.

End-User Analysis

The end-user segment of the AI-powered personalized oncology nutrition market is comprised of hospitals and clinics, cancer care centers, research institutes, homecare, and others. Hospitals and clinics represent the largest end-user group in 2025, as they are at the forefront of integrating AI-driven nutrition solutions into routine oncology care. These institutions benefit from the ability to offer comprehensive, multidisciplinary care that incorporates personalized nutrition as a key component of cancer management. AI-powered platforms enable care teams to coordinate dietary interventions with medical treatments, improving patient outcomes and streamlining clinical workflows across complex oncology cases.

Cancer care centers are rapidly adopting AI-powered personalized oncology nutrition solutions, driven by the need to provide specialized, high-quality care for complex cancer cases. These centers often have dedicated nutrition departments and are early adopters of innovative technologies that can enhance patient care. The ability to deliver individualized nutrition plans and monitor patient progress in real time is a significant advantage for cancer care centers seeking to differentiate themselves in a competitive healthcare landscape. Many of these centers are also exploring how broader oncology nutrition programs can be enhanced by layering AI-driven personalization on top of established dietary protocols.

Research institutes are playing a pivotal role in advancing the science of AI-powered personalized oncology nutrition. These organizations are at the cutting edge of developing and validating new AI algorithms, conducting clinical trials, and generating evidence to support the efficacy of personalized nutrition interventions in oncology. Collaborations between research institutes, technology companies, and healthcare providers are driving continuous innovation and expanding the evidence base for AI-driven nutrition solutions as the field matures through 2034.

Homecare is an emerging end-user segment with significant growth potential, particularly as the shift towards outpatient and remote care accelerates following the widespread normalization of telehealth. AI-powered platforms enable patients to receive personalized nutrition guidance and monitoring in the comfort of their homes, reducing the need for frequent hospital visits and supporting long-term survivorship. The "others" category includes wellness centers, rehabilitation facilities, and telehealth providers, which are increasingly incorporating AI-powered nutrition solutions into their service offerings to address the holistic needs of cancer patients across the full care continuum.

Deployment Mode Analysis

The deployment mode segment of the AI-powered personalized oncology nutrition market is divided into cloud-based and on-premises solutions. Cloud-based deployment is rapidly gaining traction due to its scalability, flexibility, and cost-effectiveness, and represented the majority of new deployments in 2025. Cloud platforms facilitate seamless data sharing and collaboration among multidisciplinary care teams, regardless of geographic location. This is particularly valuable for large healthcare networks and institutions with multiple sites, as it enables centralized management of patient data and nutrition interventions. The ability to access AI-powered tools from any device with an internet connection is also driving adoption among homecare providers and patients managing their care remotely.

On-premises deployment remains important for healthcare organizations with strict data security and compliance requirements. These solutions offer greater control over data storage and system customization, making them suitable for institutions that handle sensitive patient information or operate in regions with stringent data protection regulations. On-premises deployment is often preferred by large hospitals, research institutes, and cancer care centers with dedicated IT resources and infrastructure. However, the higher upfront costs and maintenance requirements associated with on-premises solutions can be a barrier for smaller organizations seeking to adopt AI-powered nutrition capabilities.

The choice between cloud-based and on-premises deployment is influenced by factors such as organizational size, IT capabilities, regulatory environment, and patient population characteristics. Many vendors are now offering hybrid solutions that combine the benefits of both deployment modes, allowing healthcare providers to tailor their technology infrastructure to their specific operational and compliance needs. As the market evolves through 2034, the trend towards cloud-based deployment is expected to accelerate, driven by advancements in cybersecurity, interoperability standards, and regulatory compliance frameworks that are making cloud environments increasingly viable for sensitive clinical data.

The deployment mode landscape is also being shaped by the increasing integration of AI-powered nutrition solutions with other digital health platforms, such as electronic health records, telemedicine systems, and remote patient monitoring devices. This integration is facilitating the creation of comprehensive, data-driven care ecosystems that support personalized oncology nutrition at every stage of the patient journey, from initial diagnosis through active treatment and into long-term survivorship.

Opportunities & Threats

The AI-powered personalized oncology nutrition market is rife with opportunities for innovation, expansion, and improved patient outcomes through the 2026-2034 forecast period. One of the most promising opportunities lies in the integration of AI-powered nutrition platforms with genomics and precision medicine initiatives. As the understanding of cancer biology deepens, AI algorithms can leverage genomic data to develop highly targeted nutrition interventions that address individual metabolic pathways and treatment responses. This convergence of AI, genomics, and nutrition science has the potential to revolutionize cancer care, offering new avenues for disease prevention, management, and long-term survivorship planning.

Another major opportunity is the expansion of AI-powered personalized oncology nutrition solutions into emerging markets and underserved populations. As healthcare systems in Asia Pacific, Latin America, and the Middle East and Africa continue to modernize, there is significant potential to improve cancer outcomes through the adoption of digital health technologies. Localized AI models that account for regional dietary habits, genetic diversity, and healthcare infrastructure can drive adoption and deliver meaningful benefits to diverse patient populations. Strategic partnerships between global technology providers, local healthcare organizations, and government agencies can facilitate market entry and foster sustainable growth. The rapid evolution of AI-driven digital twin technology for oncology trials also presents a compelling opportunity to simulate and validate personalized nutrition interventions before clinical deployment.

Despite these opportunities, the market faces several restraining factors that could hinder its growth trajectory. Data privacy and security concerns are paramount, particularly as AI-powered platforms handle sensitive patient information and integrate with multiple healthcare systems. Ensuring compliance with global data protection regulations, such as HIPAA and GDPR, is a complex and ongoing challenge for market participants operating across jurisdictions. Additionally, the high initial costs of implementing AI-powered solutions and the need for specialized training can be barriers for smaller healthcare organizations. Addressing these challenges will require sustained investment in cybersecurity, workforce development, and stakeholder education to build confidence in AI-powered nutrition tools across all care settings.

Regional Outlook

North America remains the dominant regional market for AI-powered personalized oncology nutrition, accounting for approximately 41% of global revenue in 2025, or approximately USD 294.6 million. The region's leadership is underpinned by advanced healthcare infrastructure, a high prevalence of cancer, and a strong culture of innovation in digital health. The United States, in particular, is home to many leading technology providers, cancer care centers, and clinical research organizations that are driving adoption of AI-powered nutrition solutions. The presence of favorable reimbursement policies, active FDA engagement with digital health tools, and supportive regulatory frameworks further accelerates market growth in North America through the forecast period.

Get Free Sample Report

Europe is the second-largest regional market, representing about 28.5% of global revenue or approximately USD 204.8 million in 2025. The region benefits from robust research activity, government support for personalized medicine initiatives, and a well-developed healthcare ecosystem that values multidisciplinary cancer care. Countries such as Germany, the United Kingdom, and France are at the forefront of integrating AI-powered nutrition platforms into oncology care pathways. The European market is expected to grow at a healthy CAGR through 2034, driven by ongoing investments in healthcare IT infrastructure, the European Health Data Space initiative, and cross-border collaborations in cancer research and digital health innovation.

The Asia Pacific region is emerging as a high-growth market, accounting for approximately 19.5% of global revenue or approximately USD 140.1 million in 2025. Rapidly increasing cancer incidence, rising healthcare expenditures, and growing awareness of the benefits of personalized nutrition are key drivers in this region. Countries such as China, Japan, South Korea, and India are investing heavily in digital health solutions and AI-enabled oncology platforms, and local technology providers are developing AI models tailored to regional dietary patterns and genetic profiles. The Asia Pacific market is expected to achieve the highest CAGR among all regions through 2034, reflecting its vast untapped potential and dynamic innovation landscape. Latin America and the Middle East and Africa together represent approximately 11% of global revenue in 2025, with both regions poised for accelerating growth as cancer care infrastructure expands and digital health awareness increases among clinicians and patients.

Competitor Outlook

The competitive landscape of the AI-powered personalized oncology nutrition market in 2025 is characterized by a mix of established technology companies, specialized digital health firms, and innovative startups. Market competition is intensifying as companies race to develop more sophisticated AI algorithms, expand their product portfolios, and forge partnerships with leading healthcare providers and cancer centers. The ability to offer comprehensive, interoperable solutions that address the full spectrum of oncology nutrition needs, from initial assessment through long-term survivorship, is a key differentiator. Companies are also investing heavily in research and development to stay ahead of evolving clinical guidelines and regulatory requirements as the market scales through 2034.

Strategic collaborations and mergers and acquisitions are common as companies seek to enhance their technical capabilities and expand their geographic reach. Partnerships between software vendors, service providers, research organizations, and healthcare networks are driving the development of integrated care platforms that combine AI-powered nutrition planning, patient monitoring, and treatment support. This collaborative approach is fostering innovation and accelerating the adoption of personalized oncology nutrition solutions across diverse care settings, from major academic medical centers to community-based clinics and homecare environments.

Data security, regulatory compliance, and user experience are emerging as critical areas of focus for market participants in 2025. Leading companies are prioritizing the development of secure, user-friendly platforms that comply with global data protection standards and support seamless integration with existing healthcare IT systems. Continuous investment in customer support, training, and education is also essential to ensure successful implementation and sustained adoption of AI-powered solutions. Companies that can demonstrate measurable improvements in patient outcomes and clinical efficiency through real-world evidence are increasingly well-positioned to win institutional contracts and expand their market presence.

Some of the major companies operating in the AI-powered personalized oncology nutrition market include Savor Health, Carevive Systems, OncoPower, DayTwo, Foodsmart, Viome, Nutrino Health (Medtronic), Tempus AI, Flatiron Health, and IBM Watson Health. Savor Health is a recognized pioneer in delivering AI-driven personalized nutrition support specifically designed for cancer patients, offering tailored meal recommendations and educational resources at scale. Carevive Systems provides intelligent care planning platforms that integrate nutrition management into broader oncology care coordination workflows. DayTwo leverages microbiome science and AI to deliver highly individualized dietary guidance, while Viome offers gut intelligence tools that complement oncology nutrition strategies. Tempus AI and Flatiron Health bring deep oncology data analytics capabilities that are increasingly being applied to personalized nutrition use cases, reflecting the growing convergence of precision oncology data and dietary science in 2025 and beyond.

Key Players

• Savor Health
• Carevive Systems
• OncoPower
• DayTwo
• Foodsmart
• Viome
• Nutrino Health (Medtronic)
• Suggestic
• Genopalate
• Nutrigenomix
• IBM Watson Health
• Noom Health
• Vida Health
• CarePredict
• Evidation Health
• Tempus AI
• Flatiron Health